Broker Name: OCBC Investment Research
Date of Report: 6 November 2025
Excerpt from OCBC Investment Research report.
Report Summary
- Parkway Life REIT (PLIFE) is one of Asia’s largest listed healthcare REITs, with a diversified portfolio of 75 healthcare assets across Singapore, Japan, Malaysia, and France, valued at SGD2.46b. The REIT is seen as a defensive investment, benefiting from long-term leases and exposure to secular trends like ageing populations and medical tourism.
- PLIFE’s 9M25 distribution per unit (DPU) increased 2.3% year-on-year, supported by new acquisitions and currency appreciation. Despite a marginally higher cost of debt expected in FY26, the REIT maintains healthy credit metrics and continues to grow distributions, with further upside possible from tax exemptions and future CAPEX completions. The fair value estimate is SGD4.82, with a BUY rating reiterated.
above is an excerpt from a report by OCBC Investment Research. Clients of OCBC Investment Research can be the first to access the full report from the OCBC Investment Research website :
https://www.ocbc.com/investments/research
